Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man

Cell Metabolism

Volumn 14, Issue 6, 2011, Pages 811-818

  Holleboom, Adriaan G ^a   Karlsson, Helen ^b,e   Lin, Ruei Shiuan ^c   Beres, Thomas M ^c   Sierts, Jeroen A ^a   Herman, Daniel S ^d   Stroes, Erik S G ^a   Aerts, Johannes M ^a   Kastelein, John J P ^a   Motazacker, Mohammad M ^a   Dallinga Thie, Geesje M ^a   Levels, Johannes H M ^a   Zwinderman, Aeilko H ^a   Seidman, Jonathan G ^d   Seidman, Christine E ^d   Ljunggren, Stefan ^e   Lefeber, Dirk J ^f   Morava, Eva ^f   Wevers, Ron A ^f   Fritz, Timothy A ^g   Tabak, Lawrence A ^c   Lindahl, Mats ^e   Hovingh, G Kees ^a   Kuivenhoven, Jan Albert ^a,h   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Department of Clinical Immunology and Transfusion Medicine   (Sweden)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e LINKÖPING UNIVERSITY   (Sweden)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIALIDASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLYCOSYLATION; HETEROZYGOSITY LOSS; HUMAN; LIPID HYDROLYSIS; LIPID METABOLISM; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PROCESSING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEIN C-III; CHOLESTEROL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GLYCOSYLATION; HETEROZYGOTE; HUMANS; LIPASE; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MUTATION; N-ACETYLGALACTOSAMINYLTRANSFERASES; PEPTIDES; POSTPRANDIAL PERIOD; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 82955239839     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2011.11.005     Document Type: Article

References (38)

1. U. Beisiegel, W. Weber, and G. Bengtsson-Olivecrona Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein Proc. Natl. Acad. Sci. USA 88 1991 8342 8346 (Pubitemid 21915352)
2. A. Bruneel, T. Robert, D.J. Lefeber, G. Benard, E. Loncle, A. Djedour, G. Durand, and N. Seta Two-dimensional gel electrophoresis of apolipoprotein C-III and other serum glycoproteins for the combined screening of human congenital disorders of O- and N-glycosylation Proteomics Clin. App. 1 2007 321 324
3. S. Eisenberg, D.W. Bilheimer, and R.I. Levy The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins Biochim. Biophys. Acta 280 1972 94 104
4. T.A. Gerken, O. Jamison, C.L. Perrine, J.C. Collette, H. Moinova, L. Ravi, S.D. Markowitz, H. Shen, H. Patel, and L.A. Tabak Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases J. Biol. Chem. 286 2011 14493 14507
5. F.K. Hagen, K.G. Ten Hagen, T.M. Beres, M.M. Balys, B.C. VanWuyckhuyse, and L.A. Tabak cDNA cloning and expression of a novel UDP-N-acetyl-D- galactosamine:polypeptide N-acetylgalactosaminyltransferase J. Biol. Chem. 272 1997 13843 13848 (Pubitemid 27224824)
6. D.S. Herman, G.K. Hovingh, O. Iartchouk, H.L. Rehm, R. Kucherlapati, J.G. Seidman, and C.E. Seidman Filter-based hybridization capture of subgenomes enables resequencing and copy-number detection Nat. Methods 6 2009 507 510
7. H.U. Jabs, and G. Assmann Characterization of an apolipoprotein C-III mutant by high-performance liquid chromatography and time-of-flight secondary ion mass spectrometry J. Chromatogr. A 414 1987 323 333 (Pubitemid 17041683)
8. M.C. Jong, M.H. Hofker, and L.M. Havekes Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3 Arterioscler. Thromb. Vasc. Biol. 19 1999 472 484 (Pubitemid 29135144)
9. H. Karlsson, P. Leanderson, C. Tagesson, and M. Lindahl Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry Proteomics 5 2005 1431 1445
10. M.L. Kashyap, B.A. Hynd, K. Robinson, and P.S. Gartside Abnormal preponderance of sialylated apolipoprotein CIII in triglyceride rich lipoproteins in type V hyperlipoproteinemia Metabolism 30 1981 111 118 (Pubitemid 11154390)
11. S. Kathiresan, O. Melander, C. Guiducci, A. Surti, N.P. Burtt, M.J. Rieder, G.M. Cooper, C. Roos, B.F. Voight, and A.S. Havulinna Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans Nat. Genet. 40 2008 189 197 (Pubitemid 351171402)
12. C.S. Ku, E.Y. Loy, Y. Pawitan, and K.S. Chia The pursuit of genome-wide association studies: where are we now? J. Hum. Genet. 55 2010 195 206
13. J.H. Levels, L.C. Lemaire, A.E. van den Ende, S.J. van Deventer, and J.J. van Lanschot Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure Crit. Care Med. 31 2003 1647 1653 (Pubitemid 36714216)
14. C. Li Genetics and regulation of angiopoietin-like proteins 3 and 4 Curr. Opin. Lipidol. 17 2006 152 156
15. S. Luttmann, A. von Eckardstein, W. Wei, H. Funke, E. Kohler, R.W. Mahley, and G. Assmann Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III (Asp45→Asn), in a Turkish patient J. Lipid Res. 35 1994 1431 1440 (Pubitemid 24251038)
16. H. Maeda, H. Uzawa, and R. Kamei Unusual familial lipoprotein C-III associated with apolipoprotein C-III-O preponderance Biochim. Biophys. Acta 665 1981 578 585 (Pubitemid 11011398)
17. H. Maeda, R.K. Hashimoto, T. Ogura, S. Hiraga, and H. Uzawa Molecular cloning of a human apoC-III variant: Thr 74-Ala 74 mutation prevents O-glycosylation J. Lipid Res. 28 1987 1405 1409 (Pubitemid 18025874)
18. J.F. Mauger, P. Couture, N. Bergeron, and B. Lamarche Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism J. Lipid Res. 47 2006 1212 1218 (Pubitemid 43830713)
19. W.J. McConathy, J.C. Gesquiere, H. Bass, A. Tartar, J.C. Fruchart, and C.S. Wang Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III J. Lipid Res. 33 1992 995 1003
20. M.C. Nierman, J. Rip, J.A. Kuivenhoven, D.H. van Raalte, B.A. Hutten, N. Sakai, J.J. Kastelein, and E.S. Stroes Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance Metabolism 54 2005 1499 1503 (Pubitemid 41527020)
21. P. Nilsson-Ehle, and M.C. Schotz A stable, radioactive substrate emulsion for assay of lipoprotein lipase J. Lipid Res. 17 1976 536 541
22. B.C. O'Connell, and L.A. Tabak Separation of glycopeptides from in vitro O-glycosylation reactions using C18 cartridges Anal. Biochem. 210 1993 423 425 (Pubitemid 23171041)
23. T.I. Pollin, C.M. Damcott, H. Shen, S.H. Ott, J. Shelton, R.B. Horenstein, W. Post, J.C. McLenithan, L.F. Bielak, and P.A. Peyser A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection Science 322 2008 1702 1705
24. J. Rip, M.C. Nierman, C.J. Ross, J.W. Jukema, M.R. Hayden, J.J. Kastelein, E.S. Stroes, and J.A. Kuivenhoven Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation Arterioscler. Thromb. Vasc. Biol. 26 2006 1236 1245 (Pubitemid 44305366)
25. A. Roghani, and V.I. Zannis Mutagenesis of the glycosylation site of human ApoCIII. O-linked glycosylation is not required for ApoCIII secretion and lipid binding J. Biol. Chem. 263 1988 17925 17932 (Pubitemid 19005067)
26. K.T. Schjoldager, M.B. Vester-Christensen, E.P. Bennett, S.B. Levery, T. Schwientek, W. Yin, O. Blixt, and H. Clausen O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids J. Biol. Chem. 285 2010 36293 36303
27. F. Shelburne, J. Hanks, W. Meyers, and S. Quarfordt Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat J. Clin. Invest. 65 1980 652 658 (Pubitemid 10179726)
28. A. Shevchenko, and A. Shevchenko Evaluation of the efficiency of in-gel digestion of proteins by peptide isotopic labelling and MALDI mass spectrometry Anal. Biochem. 296 2001 279 283 (Pubitemid 32868510)
29. J. Stocks, G. Holdsworth, and D. Galton Hypertriglyceridaemia associated with an abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-III-2 Lancet 2 1979 667 671 (Pubitemid 10236973)
30. K.G. Ten Hagen, T.A. Fritz, and L.A. Tabak All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases Glycobiology 13 2003 1R 16R (Pubitemid 36372510)
31. T.M. Teslovich, K. Musunuru, A.V. Smith, A.C. Edmondson, I.M. Stylianou, M. Koseki, J.P. Pirruccello, S. Ripatti, D.I. Chasman, and C.J. Willer Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
32. P. Vaith, G. Assmann, and G. Uhlenbruck Characterization of the oligosaccharide side chain of apolipoprotein C-III from human plasma very low density lipoproteins Biochim. Biophys. Acta 541 1978 234 240 (Pubitemid 8360491)
33. H.H. van Barlingen, L.A. Kock, F.H. de Man, D.W. Erkelens, and T.W. de Bruin In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia Atherosclerosis 121 1996 75 84
34. K.W. van Dijk, P.C. Rensen, P.J. Voshol, and L.M. Havekes The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? Curr. Opin. Lipidol. 15 2004 239 246 (Pubitemid 38716555)
35. E. Windler, and R.J. Havel Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver J. Lipid Res. 26 1985 556 565 (Pubitemid 15073727)
36. E. Windler, Y. Chao, and R.J. Havel Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins J. Biol. Chem. 255 1980 8303 8307 (Pubitemid 11245947)
37. S. Wopereis, S. Grunewald, E. Morava, J.M. Penzien, P. Briones, M.T. Garcia-Silva, P.N. Demacker, K.M. Huijben, and R.A. Wevers Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis Clin. Chem. 49 2003 1839 1845 (Pubitemid 37340318)
38. R. Zechner The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism Curr. Opin. Lipidol. 8 1997 77 88 (Pubitemid 27235067)